ACB
Aurora Cannabis Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$3.95
+1.54%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 290.3M | 320.6M | 343.3M | 270.3M | 223.8M |
| Cost of Revenue | 197.1M | 183.9M | 155.7M | 138.8M | 209.0M |
| Gross Profit | 93.1M | 136.7M | 187.6M | 131.5M | 14.8M |
| Operating Expenses | |||||
| R&D Expense | 5.7M | 4.0M | 3.7M | 3.6M | 5.8M |
| SG&A Expense | 169.3M | 166.2M | 166.5M | 156.9M | 170.5M |
| General & Admin Expense | 82.4M | 106.6M | 110.2M | 104.9M | 102.4M |
| Selling & Marketing Expense | 46.0M | 59.6M | 56.3M | 51.9M | 68.0M |
| Other Expenses | 4.2M | 13.1M | 12.5M | 17.5M | 45.7M |
| Total Operating Expenses | 179.2M | 183.3M | 182.7M | 177.9M | 222.0M |
| Cost and Expenses | 376.3M | 367.3M | 338.3M | 316.7M | 431.0M |
| Operating Income (EBIT) | (86.1M) | (46.7M) | 4.9M | (46.5M) | (207.2M) |
| Non-Operating | |||||
| Interest Income | 5.1M | 5.8M | 11.5M | 12.8M | 19.0M |
| Interest Expense | 4.8M | 1.8M | 8.4M | 14.2M | 39.5M |
| Net Interest Income | 331.0K | 4.0M | 3.1M | (1.4M) | (20.5M) |
| Other Non-Op Income/Expense | 45.4M | (9.9M) | 15.4M | (13.1M) | (576.5M) |
| Non-Operating Income (excl Interest) | (16.7M) | 8.1M | (23.9M) | (1.0M) | (19.6M) |
| EBT (Pre-Tax Income) | (40.7M) | (56.5M) | 20.4M | (59.6M) | (783.7M) |
| Income Tax Expense | 2.5M | 2.1M | 4.6M | (554.0K) | 16.5M |
| Bottom Line | |||||
| Net Income | (110.7M) | (121.8M) | 1.6M | (69.3M) | (816.6M) |
| Earnings from Cont. Ops | (43.2M) | (58.6M) | 15.8M | (59.0M) | (800.2M) |
| Earnings from Discont. Ops | (72.8M) | (77.3M) | (14.2M) | (10.3M) | (23.7M) |
| Bottom Line Net Income | (110.7M) | (121.8M) | 1.6M | (69.3M) | (793.0M) |
| Per Share | |||||
| Basic EPS | ($1.93) | ($2.15) | $0.03 | ($1.28) | ($8.17) |
| Diluted EPS | ($1.93) | ($2.14) | $0.03 | ($1.28) | ($8.17) |
| Revenue Per Share | $4.71 | $5.65 | $6.26 | $5.27 | $6.93 |
| Shares | |||||
| Basic Shares Outstanding | 61.7M | 56.7M | 54.9M | 51.3M | 32.3M |
| Diluted Shares Outstanding | 61.7M | 57.3M | 55.8M | 51.3M | 32.3M |
| Profitability Metrics | |||||
| EBITDA | (67.0M) | (50.9M) | 51.3M | (12.3M) | (135.0M) |
| D&A | 2.4M | 3.8M | 22.5M | 33.1M | 52.6M |
| EBIT | (69.4M) | (54.7M) | 28.8M | (45.4M) | (187.6M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026